secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K/A
Filed at:   2022-05-24T23:59:59+00:00
Accession:  0001104659-22-064100
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech files 8-K/A to include BDO's letter confirming auditor change agreement
--------------------------------------------------------------------------------

- Original 8-K on May 13, 2022 disclosed dismissal of BDO LLP and appointment of PwC as auditor.
- Amendment adds BDO's letter dated May 20, 2022 (Exhibit 16.1) confirming agreement with company's statements.
- No changes to original disclosures; purely procedural addition with no financial impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922064100/0001104659-22-064100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922064100/tm2216229d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-064100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer